The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)

Therapeutic control of the methotrexate (MT) polyglutamates (MTPG) level in erythrocytes can be an objective marker of the effective dose of MT prescribed for rheumatoid arthritis (RA).Objective: to assess the relationship between the level of MTPG in red blood cells and efficacy of the MT dose used...

Full description

Bibliographic Details
Main Authors: G. I. Gridneva, Yu. V. Muravyev, N. V. Demidova, E. S. Aronova, A. V. Pivanova, M. A. Borisova, S. I. Glukhova, A. S. Starkova, N. M. Savushkina, S. O. Krasnenko, K. S. Nurbaeva, N. V. Baimeeva, I. A. Tyurin, A. M. Lila
Format: Article
Language:Russian
Published: IMA PRESS LLC 2019-05-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2701
_version_ 1797862635064000512
author G. I. Gridneva
Yu. V. Muravyev
N. V. Demidova
E. S. Aronova
A. V. Pivanova
M. A. Borisova
S. I. Glukhova
A. S. Starkova
N. M. Savushkina
S. O. Krasnenko
K. S. Nurbaeva
N. V. Baimeeva
I. A. Tyurin
A. M. Lila
author_facet G. I. Gridneva
Yu. V. Muravyev
N. V. Demidova
E. S. Aronova
A. V. Pivanova
M. A. Borisova
S. I. Glukhova
A. S. Starkova
N. M. Savushkina
S. O. Krasnenko
K. S. Nurbaeva
N. V. Baimeeva
I. A. Tyurin
A. M. Lila
author_sort G. I. Gridneva
collection DOAJ
description Therapeutic control of the methotrexate (MT) polyglutamates (MTPG) level in erythrocytes can be an objective marker of the effective dose of MT prescribed for rheumatoid arthritis (RA).Objective: to assess the relationship between the level of MTPG in red blood cells and efficacy of the MT dose used by RA patients.Subjects and methods. The study included 60 patients with RA (44 women and 16 men over 18 years) who met the criteria of the American College of Rheumatology and the European League Against Rheumatism (ACR/EULAR) 2010 and received MT ≥20 mg/week subcutaneously for ≥12 weeks. The patients were divided into two groups of comparable age, sex, alcohol intake, number of smokers, body mass index (BMI), depending on the presence (group 1; n=30) or absence (group 2; n=30) of the effect of MT, according to the EULAR efficacy criteria (DAS28). The concentration of MTPG (total MTPG and metabolites of MTPG 1, 2, 3, 4, 5) was determined in erythrocytes by high-performance liquid chromatography with mass spectrometric detection.Results and discussion. It was found that the levels of total MTPG and MTPG1, 2, 3, 5 in erythrocytes did not differ in groups of responders and nonresponders, and the dose of MT was comparable in both groups. At the same time, the level of MTPG4 in the first group was significantly higher (26.4±6.1 nmol/l; p=0.023) than in the second one (22.1±6.8 nmol/l). Analysis of the ROC curve showed that the values of MTPG4 <22.5 nmol/l corresponded to the absence of effect of MT. The area under the curve was 0.672 (95% confidence interval 0.536–0.808 (p=0.022), sensitivity 77%, specificity 53.3%.Conclusion. For effective treatment of patients with RA MT dose should provide MTPG4 level in red blood cells ≥22.5 nmol/l.
first_indexed 2024-04-09T22:22:33Z
format Article
id doaj.art-2c0097132dfd47aba6d2730b8cff2381
institution Directory Open Access Journal
issn 1995-4484
1995-4492
language Russian
last_indexed 2024-04-09T22:22:33Z
publishDate 2019-05-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj.art-2c0097132dfd47aba6d2730b8cff23812023-03-22T13:45:55ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922019-05-0157217117410.14412/1995-4484-2019-171-1742472The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)G. I. Gridneva0Yu. V. Muravyev1N. V. Demidova2E. S. Aronova3A. V. Pivanova4M. A. Borisova5S. I. Glukhova6A. S. Starkova7N. M. Savushkina8S. O. Krasnenko9K. S. Nurbaeva10N. V. Baimeeva11I. A. Tyurin12A. M. Lila13V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaNational Center for Mental HealthAcute Poisoning Center for the Mentally Ill, N.V. Sklifosovsky Research Institute of Emergency CareV.A. Nasonova Research Institute of RheumatologyTherapeutic control of the methotrexate (MT) polyglutamates (MTPG) level in erythrocytes can be an objective marker of the effective dose of MT prescribed for rheumatoid arthritis (RA).Objective: to assess the relationship between the level of MTPG in red blood cells and efficacy of the MT dose used by RA patients.Subjects and methods. The study included 60 patients with RA (44 women and 16 men over 18 years) who met the criteria of the American College of Rheumatology and the European League Against Rheumatism (ACR/EULAR) 2010 and received MT ≥20 mg/week subcutaneously for ≥12 weeks. The patients were divided into two groups of comparable age, sex, alcohol intake, number of smokers, body mass index (BMI), depending on the presence (group 1; n=30) or absence (group 2; n=30) of the effect of MT, according to the EULAR efficacy criteria (DAS28). The concentration of MTPG (total MTPG and metabolites of MTPG 1, 2, 3, 4, 5) was determined in erythrocytes by high-performance liquid chromatography with mass spectrometric detection.Results and discussion. It was found that the levels of total MTPG and MTPG1, 2, 3, 5 in erythrocytes did not differ in groups of responders and nonresponders, and the dose of MT was comparable in both groups. At the same time, the level of MTPG4 in the first group was significantly higher (26.4±6.1 nmol/l; p=0.023) than in the second one (22.1±6.8 nmol/l). Analysis of the ROC curve showed that the values of MTPG4 <22.5 nmol/l corresponded to the absence of effect of MT. The area under the curve was 0.672 (95% confidence interval 0.536–0.808 (p=0.022), sensitivity 77%, specificity 53.3%.Conclusion. For effective treatment of patients with RA MT dose should provide MTPG4 level in red blood cells ≥22.5 nmol/l.https://rsp.mediar-press.net/rsp/article/view/2701methotrexatepolyglutamatestherapeutic controlrheumatoid arthritis
spellingShingle G. I. Gridneva
Yu. V. Muravyev
N. V. Demidova
E. S. Aronova
A. V. Pivanova
M. A. Borisova
S. I. Glukhova
A. S. Starkova
N. M. Savushkina
S. O. Krasnenko
K. S. Nurbaeva
N. V. Baimeeva
I. A. Tyurin
A. M. Lila
The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
Научно-практическая ревматология
methotrexate
polyglutamates
therapeutic control
rheumatoid arthritis
title The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
title_full The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
title_fullStr The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
title_full_unstemmed The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
title_short The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
title_sort relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes pilot study
topic methotrexate
polyglutamates
therapeutic control
rheumatoid arthritis
url https://rsp.mediar-press.net/rsp/article/view/2701
work_keys_str_mv AT gigridneva therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT yuvmuravyev therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT nvdemidova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT esaronova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT avpivanova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT maborisova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT siglukhova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT asstarkova therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT nmsavushkina therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT sokrasnenko therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT ksnurbaeva therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT nvbaimeeva therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT iatyurin therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT amlila therelationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT gigridneva relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT yuvmuravyev relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT nvdemidova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT esaronova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT avpivanova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT maborisova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT siglukhova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT asstarkova relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT nmsavushkina relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT sokrasnenko relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT ksnurbaeva relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT nvbaimeeva relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT iatyurin relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy
AT amlila relationshipbetweentheefficacyofmethotrexateinrheumatoidarthritisandtheachievedlevelofitspolyglutamatesinerythrocytespilotstudy